Clinical Trials Logo

Other Preterm Infants clinical trials

View clinical trials related to Other Preterm Infants.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT01772927 Not yet recruiting - Failure to Thrive Clinical Trials

Clinical Tolerance of Numeta 13%

BAXTERULG2
Start date: January 2013
Phase: N/A
Study type: Observational

Numeta G13% is a triple chamber bag including amino acids plus electrolytes, glucose and lipids, dedicated for parenteral nutrition in preterm newborn infants when oral/enteral nutrition is not possible, insufficient or contra indicated. The product has been registered in 18 countries in Europe via a decentralized procedure that ended 15th December 2010. The present study want to evaluate the use of Numeta 13% as standard medical prescription in the NICU of the university of Liege. It is a prospective, monocentric, non-interventional, non comparative, open-labeled data collection of record keeping, nutritional intakes from the bags, additional intakes as well as blood and urine biochemical markers currently evaluated in the NICU. The data will be collected only in VLBWI < 1500 g receiving Numeta G13% from day of birth (day 1) until parenteral nutrition (PN) decreases below 20% of the targeted intakes 2 days in a row as a quality control of the new solution in clinical practice. Indication for PN and daily prescription will follow the protocol in use in the NICU on behalf of the investigators